Healthcare provider profile · identity verified

Tobin Scott Crow, DO

Family Practice · MONETT, MO · NPI 1033397567

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	632	160
Losartan Potassium	Losartan Potassium	423	112
Lisinopril	Lisinopril	401	108
Amlodipine Besylate	Amlodipine Besylate	342	98
Levothyroxine Sodium	Levothyroxine Sodium	341	79
Metoprolol Succinate	Metoprolol Succinate	252	74
Gabapentin	Gabapentin	227	51
Metformin Hcl	Metformin Hcl	216	58
Omeprazole	Omeprazole	196	51
Tamsulosin Hcl	Tamsulosin Hcl	190	46
Rosuvastatin Calcium	Rosuvastatin Calcium	185	49
Hydrochlorothiazide	Hydrochlorothiazide	176	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	160	28
Glimepiride	Glimepiride	146	39
Hydralazine Hcl	Hydralazine Hcl	139	40
Duloxetine Hcl	Duloxetine Hcl	130	31
Albuterol Sulfate Hfa	Albuterol Sulfate	125	37
Pantoprazole Sodium	Pantoprazole Sodium	124	32
Montelukast Sodium	Montelukast Sodium	118	29
Sertraline Hcl	Sertraline Hcl	114	27
Carvedilol	Carvedilol	111	26
Lorazepam	Lorazepam	107	18
Metformin Hcl Er	Metformin Hcl	102	25
Fluticasone Propionate	Fluticasone Propionate	101	32
Shingrix	Varicella-Zoster Ge/As01b/Pf	100	84
Meloxicam	Meloxicam	93	22
Eliquis	Apixaban	89	17
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	88	88
Simvastatin	Simvastatin	88	23
Escitalopram Oxalate	Escitalopram Oxalate	85	24
Pregabalin	Pregabalin	84	16
Metoprolol Tartrate	Metoprolol Tartrate	79	16
Allopurinol	Allopurinol	77	21
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	72	72
Ozempic	Semaglutide	70	15
Jardiance	Empagliflozin	69	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	19
Zolpidem Tartrate	Zolpidem Tartrate	69	suppressed
Clopidogrel	Clopidogrel Bisulfate	68	17
Famotidine	Famotidine	67	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	17
Tramadol Hcl	Tramadol Hcl	64	21
Warfarin Sodium	Warfarin Sodium	63	11
Buspirone Hcl	Buspirone Hcl	62	13
Citalopram Hbr	Citalopram Hydrobromide	62	15
Alprazolam	Alprazolam	60	11
Tizanidine Hcl	Tizanidine Hcl	60	18
Pioglitazone Hcl	Pioglitazone Hcl	58	17
Trazodone Hcl	Trazodone Hcl	56	20
Furosemide	Furosemide	55	17
Potassium Chloride	Potassium Chloride	55	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	suppressed
Valsartan	Valsartan	52	14
Donepezil Hcl	Donepezil Hcl	51	11
Pravastatin Sodium	Pravastatin Sodium	50	15
Ropinirole Hcl	Ropinirole Hcl	50	suppressed
Celecoxib	Celecoxib	49	suppressed
Irbesartan	Irbesartan	48	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	45	suppressed
Symbicort	Budesonide/Formoterol Fumarate	44	suppressed
Finasteride	Finasteride	43	11
Hydroxyzine Hcl	Hydroxyzine Hcl	43	12
Alendronate Sodium	Alendronate Sodium	42	16
Cephalexin	Cephalexin	37	34
Fenofibrate	Fenofibrate	36	suppressed
Estradiol	Estradiol	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Spironolactone	Spironolactone	33	12
Baclofen	Baclofen	32	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	18
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Ondansetron Odt	Ondansetron	27	13
Ezetimibe	Ezetimibe	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	15
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Lovastatin	Lovastatin	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Glipizide	Glipizide	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Primidone	Primidone	19	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Ketoconazole	Ketoconazole	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Atenolol	Atenolol	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Azithromycin	Azithromycin	14	13
Carbamazepine	Carbamazepine	14	suppressed
Diazepam	Diazepam	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Prednisone	Prednisone	14	11
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Novolin R	Insulin Regular, Human	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Clonidine	Clonidine	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Etodolac	Etodolac	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Nystatin	Nystatin	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error